Blog

BLOG: Ocular biomarkers for Alzheimer’s disease

January 17, 2020
by Leonard V. Messner OD, FAAO Alzheimer’s disease is a global disease of central nervous system dysfunction. Although public discourse about…

Kala completes enrollment in STRIDE 3 trial

January 17, 2020
Kala Pharmaceuticals has completed enrollment in the STRIDE 3 trial for KPI-121 0.25%, a treatment for temporary dry eye relief, according to a press…

Q&A: Vision training to improve athletic performance

January 16, 2020
Athletes are continually looking for ways to improve their performance and gain an advantage in training to give them a leg up on their competition. …
Meeting News

Glaukos leverages acquisitions to enter new ophthalmology spaces

January 16, 2020
With recent acquisitions, Glaukos now has multiple products in development that expand its reach outside of the glaucoma space and into more…
In the JournalsPerspective

Study finds prostaglandins change ocular surface

January 16, 2020
The ocular surface was found to change in patients treated with prostaglandin analogues, according to a literature review published in the Journal of

First US patient implanted with wireless retinal device

January 16, 2020
A surgeon at the UPMC Eye Center has implanted the first patient in the United States with a wireless retinal device to restore partial sight to…
Residency to Retirement Resource Center

Where does your financial advisor’s duty lie?

January 16, 2020
In the first article of this three-part series on investing we discussed the potential pitfalls of going it alone; current evidence suggests that…
In the Journals

Ocular changes differ in ground-based analogue of weightlessness

January 15, 2020
Subjects who underwent a ground-based analogue of weightlessness experienced greater peripapillary total retinal thickness but less choroidal…

FDA, NIDA call for marijuana legislation to advance public health

January 15, 2020
Leaders from the FDA and the National Institute on Drug Abuse said during a recent House Committee on Energy and Commerce hearing that there is a…
Meeting News

Oyster Point’s dry eye nasal spray meets phase 2 endpoints

January 15, 2020
Oyster Point Pharma’s nasal spray treatment for dry eye disease has met its primary endpoints in the phase 2 MYSTIC trial, CEO and President…

CustomFlex artificial iris receives transitional pass-through payment status

January 15, 2020
The CustomFlex artificial iris was granted transitional pass-through payment status from CMS, effective Jan. 1, 2020. The artificial iris from VEO…
In the JournalsPerspective

OCTA of choroidal microvasculature may facilitate glaucoma diagnoses

January 15, 2020
The use of OCT angiography in examining choroidal microvasculature may expedite glaucoma diagnoses in highly myopic eyes, according to findings…

LumiThera completes Series C funding tranche

January 15, 2020
LumiThera has completed the second tranche of its Series C funding round to support clinical testing and commercialization of the Valeda light…
Meeting News

Santen plans entry in US glaucoma market

January 14, 2020
Santen plans to break into the U.S. glaucoma market in 2020 with the introduction of the DE-128 microshunt, according to a speaker at the 38th annual…
In the JournalsPerspective

Smartphone tonometer provides reliable preliminary IOP

January 14, 2020
Calculating preliminary IOP using a smartphone-based tonometer yielded similar results compared with other tonometers, according to findings…

Iveric plans design of new Zimura trial

January 14, 2020
Iveric bio announced the design of a second pivotal trial for Zimura, a complement C5 inhibitor in development for the treatment of geographic…

STAAR’s EVO, Visian ICLs receive CE mark as supplemental lens

January 14, 2020
European authorities have granted a CE mark approval to STAAR Surgical’s ICL as a supplemental or “piggyback” lens in post-cataract…
In the JournalsPerspective

Asymmetric keratoconus correction may improve visual acuity, refractive outcomes

January 13, 2020
A progressive thickness intrastromal corneal ring segment may help improve visual acuity and refractive outcomes in patients with asymmetric…

Steroid administration to change in next cohorts of Adverum’s OPTIC trial

January 13, 2020
Adverum Biotechnologies will change how patients receive steroids to manage inflammation in the third and fourth cohorts of its phase 1 OPTIC trial…
Meeting News

New glaucoma therapies provide options for patients on multiple agents

January 13, 2020
ORLANDO, Fla. – Fixed combination therapies, new single agents with targeted mechanisms of action, laser surgery and future sustained release…